Challenges |
Mitigation Measure |
Unavailability of controls |
Positive Control: use of a confirmed positive patient sample Negative Control: use water/universal transport media/viral transport media |
Most methods are under development hence no validation data |
Use methods with Emergency Listing (EUL) by WHO Check https://www.who.int/diagnostics_laboratory/EUL/en/ and third party evaluated methods and perform method verification to the extent possible. |
Unavailability of EQA schemes |
Interlaboratory comparison with EPHI. |
Travel restriction adequately implement onsite evaluations |
Remote mentoring/supervision of laboratories by EPHI using Zoom or other web conferencing systems. |